TO DETERMINE THE INCIDENCE OF ACUTE KIDNEY INJURY IN PATIENTS OF COVID -19 ADMITTED IN TERTIARY CARE HOSPITALAND ITS IMPACT ON OUTCOME, BARABANKI
Kavuri Vigna Suma Lohith, Apoorv Arora, Anil Kumar Pawah, Nitin Srivastava- General Medicine
- Microbiology (medical)
- Immunology
- Immunology and Allergy
- General Agricultural and Biological Sciences
- General Earth and Planetary Sciences
- General Environmental Science
- Automotive Engineering
- Industrial and Manufacturing Engineering
- General Medicine
- General Medicine
- General Medicine
- General Medicine
Aim: To determine the incidence of acute kidney injury in patients of Coronavirus-19 disease admitted in a tertiary care hospital in Barabanki and to assess its impact on outcome. Method: A total of 117 COVID-19 patients aged >18 years were enrolled in the study. Clinical severity of the disease was assessed. Assessment of AKI was done using KDIGO AKIWG criteria. Patients were followed-up till their hospital stay. Clinical course and outcome were noted in terms of oxygenation, mechanical ventilation and ICU need and mortality. Chi-square, Independent samples 't'- test and ANOVAwere used to compare the data. Results:Age of patients ranged from 18 to 90 years. Mean age of patients was 48.19±16.99 years, 65% of them were males. Mild, moderate and severe clinical severity was found in 31.6%, 29.1% and 39.3% patients. Incidence of AKI within 48- hr of admission was 26.5%. Atotal of 77 (65.8%) patients required oxygenation, mechanical ventilation was required in 52 (44.4%) cases. Atotal of 78 (66.7%) were admitted to ICU. There were 38 (32.5%) deaths. Incidence of AKI was signicantly associated with higher clinical severity, faster mean respiratory rate and lower mean oxygen saturation at the time of admission. AKI patients had signicantly higher mean serum creatinine, serum urea and serum potassium levels at admission as compared to non-AKI group patients. AKI patients had signicantly higher at admission median LDH and ferritin levels as compared to non-AKI group patients. Mortality rates were signicantly higher in AKI (61.3%) as compared to non-AKI group patients (22.1%). Conclusion: The ndings of the study showed that COVID-19 is associated with a high risk of AKI incidence which was signicantly associated with higher clinical severity, inammation and deranged renal parameters at admission. AKI also seemed to inuence the outcome and increased the risk of mortality